首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1448360

全球心臟消融市场规模、份额、成长分析、按产品（射频(RF)、消融器）、按应用（心房颤动和扑动、心动过速）、按方法（基于导管和开放/手术）- 2024 年产业预测- 2031

Global Cardiac Ablation Market Size, Share, Growth Analysis, By Product(Radiofrequency (RF), Ablators), By Application(Atrial fibrillation & flutter, Tachycardia), By Approach(Catheter-based, and Open/Surgical) - Industry Forecast 2024-2031

出版日期: 2024年03月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球心臟消融市场规模为12.45亿美元，预计将从2023年的16.6亿美元成长到2031年的47.9亿美元，在预测期（2024-2031年）复合CAGR为14.20%。

咖啡因摄取量增加、久坐的生活习惯、过量饮酒和吸烟、药物滥用和吸烟倾向预计将导致心臟病患病率上升。世界卫生组织 (WHO) 指出，全球每年有超过 190 万人死于与烟草相关的心臟问题，而美国心臟协会 (AHA) 估计，美国每年有近 80 万人因心血管疾病死亡，占 20%与吸烟有关。技术进步和意识的提高推动了心臟消融设备的市场成长。儘管由于 COVID-19 大流行造成医疗保健设施和治疗供应中断，导致医疗保健设施和治疗供应中断，但政府措施和大公司的创新策略预计将促进该行业的大幅扩张。心律不整有多种起因，包括糖尿病和高血压等已有疾病、精神压力、心臟病、高龄以及吸烟、酗酒、吸毒、过量咖啡因和膳食补充剂等生活方式因素，强调了心律失常的多方面性。条件。心臟消融在控制心律、开放性手术和各种其他应用中发挥着至关重要的作用。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Medtronic - USA
Biosense Webster (a subsidiary of Johnson & Johnson) - USA
Boston Scientific Corporation - USA
Abbott Laboratories - USA
AtriCure, Inc. - USA
MicroPort Scientific Corporation - China
St. Jude Medical, Inc. (now part of Abbott) - USA
Biotronik SE & Co. KG - Germany
Stereotaxis, Inc. - USA
Osypka Medical GmbH - Germany

简介目录

Product Code: SQMIG35A2459

Global Cardiac Ablation Market size was valued at USD 1.245 billion in 2022 and is poised to grow from USD 1.66 billion in 2023 to USD 4.79 billion by 2031, growing at a CAGR of 14.20% during the forecast period (2024-2031).

Elevated consumption of caffeine, sedentary living habits, excessive alcohol and tobacco use, substance abuse, and smoking inclinations are anticipated to contribute to the rising prevalence of cardiac ailments. The World Health Organization (WHO) notes an annual toll of over 1.9 million global deaths attributed to tobacco-related heart issues, while the American Heart Association (AHA) estimates that cardiovascular diseases account for nearly 800,000 annual deaths in the U.S., with 20% linked to smoking. Market growth in cardiac ablation devices is being propelled by technological advancements and increased awareness. Despite a moderate setback due to the COVID-19 pandemic, which caused disruptions in healthcare facilities and treatment availability, governmental measures and innovative strategies by major corporations are expected to foster significant expansion in the sector. Cardiac arrhythmia, with diverse origins including pre-existing medical conditions like diabetes and hypertension, mental stress, heart disorders, advanced age, and lifestyle factors such as smoking, alcohol, drug use, excessive caffeine, and dietary supplements, underscores the multifaceted nature of the condition. Cardiac ablation plays a crucial role in managing cardiac rhythm, open surgery, and various other applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Ablation Market Segmental Analysis

The global Cardiac Ablation market is segmented on the basis of Product, Application, Approach, End - Use, Region. By Product, the market is segmented into Radiofrequency (RF), Ablators, Electrical ablators, Cryoablation devices, Ultrasound ablators, Others. By Application, the market is segmented into Atrial fibrillation & flutter, Tachycardia, Others. By Approach, the market is segmented into Catheter-based, Open/Surgical. By End - User, the market is segmented into Hospitals, Ambulatory surgical centers, Cardiac centers, Others. By Region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Cardiac Ablation Market

Technological advancements are revolutionizing cardiac ablation procedures, improving their efficacy and safety, which in turn, appeals to both patients and healthcare professionals.

Restraints in the Global Cardiac Ablation Market

Specialized training is essential for performing cardiac ablation procedures, and a deficiency in trained professionals may impede the growth of the market.

Market Trends of the Global Cardiac Ablation Market

There is an increasing preference for minimally invasive procedures due to their ability to reduce patient discomfort, hospitalization durations, and recovery periods.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Cardiac Ablation Market by Product

Market Overview
Radiofrequency (RF)
Ablators
Electrical ablators
Cryoablation devices
Ultrasound ablators
and Others

Global Cardiac Ablation Market by Application

Market Overview
Atrial fibrillation & flutter
Tachycardia
and Others

Global Cardiac Ablation Market by Approach

Market Overview
Catheter-based
and Open/Surgical

Global Cardiac Ablation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosense Webster (a subsidiary of Johnson & Johnson) - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation - China
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical, Inc. (now part of Abbott) - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stereotaxis, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka Medical GmbH - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments